Por: The Hill Health April 20, 2023
The company that makes a generic version of the common abortion pill mifepristone sued the Food and Drug Administration (FDA) on Wednesday in an effort to preserve access to the drug amid the chaotic fight across multiple federal courts. GenBioPro said it wants to preemptively block FDA from any action that would disrupt access to the drugs, including pulling its 2019 approval, if the Supreme Court declines to stop sweeping restrictions from... + full article
The Atlantic USA Opinion June 15, 2023
Brand-name drugmakers like to pay lower-cost rivals not to compete—and courts too often let them.Illustration by The Atlantic. Source: Getty.June 15, 2023, 7 AM ETAntiretroviral drugs are one of the pharmaceutical industry’s great achievements. They have turned HIV/AIDS from... + más
The DOJ's antitrust case against Google is ambitious but risky | CNBC
Teva to Slim Down Generic Drug Business in Turnaround Effort. The Stock Is Jumping. | MarketWatch
MarketWatch USA Business May 18, 2023
Teva’s ADR jumped 7.3% on Thursday morning, as investors awaited an investor day presentation scheduled to start at 12 p.m. Eastern. The drugmaker has been struggling since a series of ill-advised acquisitions a decade ago, notably the decision to buy Actavis Generics for... + más
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis | ABC News
What Are the Duties of A Trustee? | Forbes
Politico USA Health May 10, 2023
The Biden administration has long vowed to “follow the science” on drug approvals. But it has also pledged to aggressively defend reproductive rights. Those two promises could clash this week as two FDA panels of expert advisers vote whether to recommend the agency approve... + más
Le Krewe du Roi celebrates the state at 58th annual Mardi Gras Ball | The Advocate
Los Angeles Times USA Science May 06, 2023
U.S. health regulators are weighing the first request to make a birth control pill available without a prescription. But in an initial review posted Friday, the Food and Drug Administration raised numerous concerns about drugmaker Perrigo’s application to sell its decades-old... + más
FDA weighing 1st over-the-counter birth control pill | 10 WBNS
Time USA Politics April 20, 2023
A generic-mifepristone maker sued the U.S. Food and Drug Administration to protect access to the medical abortion pill amid a stretching from Texas to Washington. The lawsuit by GenBioPro Inc., filed Wednesday in federal court in Maryland, comes as the U.S. Supreme Court delayed... + más
Abortion pill maker GenBioPro sues West Virginia, argues FDA rules preempt state ban | CNBC
Judge extends deadline in lawsuit seeking to pull abortion pill mifepristone from U.S. until Feb. 24 | CNBC
CNBC USA Politics February 11, 2023
Used boxes of Mifepristone pills, the first drug used in a medical abortion, fill a trash at Alamo Women's Clinic in Albuquerque, New Mexico, U.S., January 11, 2023. Evelyn Hockstein ReutersA federal judge in Texas has extended until Feb. 24 the deadline in a lawsuit... + más
CVS and Walgreens plan to sell abortion pill mifepristone at pharmacies after FDA rule change | CNBC
Republicans back lawsuit to overturn FDA approval of abortion pill and pull the medication from U.S. market | CNBC
CNBC USA Health January 26, 2023
Boxes of the medication Mifepristone used to induce a medical abortion are prepared for patients at Planned Parenthood health center in Birmingham, Alabama, March 14, 2022.Evelyn Hockstein ReutersAbortion pill manufacturer GenBioPro on Wednesday sued to overturn West... + más
Drug company and doctor sue over abortion pill access, in test cases of federal power | ABC7
New lawsuits target state restrictions on abortion pills | Los Angeles Times
About iurex | Privacy Policy | Disclaimer |